Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgin A6 family like 17, pseudogene (GOLGA6L17P) is classified as a pseudogene found on human chromosome 15, originally annotated within the golgin family[3][7]. As a pseudogene, GOLGA6L17P is not expected to encode a functional protein, and accordingly, it is not considered a therapeutic target such as a receptor, enzyme, ion channel, or transporter[3][5][7]. Pseudogenes may act as regulatory non-coding RNAs, potentially influencing the expression of their protein-coding relatives or other targets by RNA interference or serving as microRNA decoys, but there is no specific evidence for GOLGA6L17P having a functional regulatory role[8]. There are no known drugs, biomarkers, or established links to disease or clinical safety concerns directly associated with this pseudogene. While the golgin family in general is linked to the Golgi apparatus and vesicle tethering, GOLGA6L17P is noncoding and not attributed with these functions[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgin A6 family like 17, pseudogene (GOLGA6L17P).